Package 27241-123-02

Brand: tadalafil

Generic: tadalafil
NDC Package

Package Facts

Identity

Package NDC 27241-123-02
Digits Only 2724112302
Product NDC 27241-123
Description

60 TABLET in 1 BOTTLE (27241-123-02)

Marketing

Marketing Status
Marketed Since 2022-07-04
Brand tadalafil
Generic tadalafil
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "e21837f2-58d2-4fb1-87b3-f751b94312a9", "openfda": {"nui": ["N0000175599", "N0000020026"], "upc": ["0327241123023"], "unii": ["742SXX0ICT"], "rxcui": ["2123194"], "spl_set_id": ["fceb8aaf-b4eb-4004-8ca4-f004eac6b314"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["Ajanta Pharma USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (27241-123-02)", "package_ndc": "27241-123-02", "marketing_start_date": "20220704"}], "brand_name": "Tadalafil", "product_id": "27241-123_e21837f2-58d2-4fb1-87b3-f751b94312a9", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "27241-123", "generic_name": "Tadalafil", "labeler_name": "Ajanta Pharma USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tadalafil", "active_ingredients": [{"name": "TADALAFIL", "strength": "20 mg/1"}], "application_number": "ANDA210392", "marketing_category": "ANDA", "marketing_start_date": "20220704", "listing_expiration_date": "20261231"}